PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
85 hedge funds and large institutions have $58.9M invested in Paratek Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
36% less capital invested
Capital invested by funds: $92.2M → $58.9M (-$33.3M)
Holders
85
Holding in Top 10
2
Calls
$580K
Puts
$482K
Top Buyers
| 1 | +$3.63M | |
| 2 | +$1.07M | |
| 3 | +$948K | |
| 4 |
BC
Bruce & Co
Chicago,
Illinois
|
+$630K |
| 5 |
GAI
General American Investors
New York
|
+$500K |
Top Sellers
| 1 | -$9.14M | |
| 2 | -$4.78M | |
| 3 | -$2.54M | |
| 4 |
APCM
Arbiter Partners Capital Management
New York
|
-$2.06M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$1.81M |